ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $459,000 | -39.8% | 2,704,513 | -4.2% | 0.00% | – |
Q2 2022 | $762,000 | -51.8% | 2,822,193 | 0.0% | 0.00% | – |
Q1 2022 | $1,580,000 | -26.3% | 2,822,193 | -7.1% | 0.00% | – |
Q4 2021 | $2,144,000 | -56.8% | 3,037,489 | -0.3% | 0.00% | – |
Q3 2021 | $4,967,000 | -18.3% | 3,047,038 | -0.3% | 0.00% | – |
Q2 2021 | $6,081,000 | +53.6% | 3,055,517 | +156.2% | 0.00% | – |
Q1 2021 | $3,960,000 | -15.5% | 1,192,697 | +1.3% | 0.00% | – |
Q4 2020 | $4,686,000 | +53.1% | 1,177,606 | +1.2% | 0.00% | – |
Q3 2020 | $3,060,000 | -14.0% | 1,163,565 | -0.9% | 0.00% | – |
Q2 2020 | $3,559,000 | +57.8% | 1,174,655 | +2.1% | 0.00% | – |
Q1 2020 | $2,255,000 | -73.1% | 1,150,702 | +0.8% | 0.00% | – |
Q4 2019 | $8,398,000 | +63.5% | 1,141,059 | +0.4% | 0.00% | – |
Q3 2019 | $5,137,000 | -52.9% | 1,136,363 | +3.9% | 0.00% | – |
Q2 2019 | $10,905,000 | -7.3% | 1,093,754 | +8.5% | 0.00% | – |
Q1 2019 | $11,769,000 | +1.5% | 1,007,630 | +4.4% | 0.00% | -100.0% |
Q4 2018 | $11,593,000 | -20.6% | 965,214 | +12.6% | 0.00% | 0.0% |
Q3 2018 | $14,606,000 | +59.7% | 857,202 | +60.0% | 0.00% | – |
Q2 2018 | $9,147,000 | – | 535,874 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|